About this trial
As much as 20-30% of all strokes are attributed to atrial fibrillation (AF), making the detection of AF highly important, as AF-related strokes are largely preventable with optimal treatment. Therefore, most guidelines recommend screening patients for AF after a stroke, although the optimal timing and choice of monitoring device for screening remain undefined. Our aim is to investigate whether AF screening as early as possible after stroke symptom onset provides a higher detection rate compared to screening after discharge. Additionally, we aim to determine if a 3-lead ECG device provides a higher detection rate compared to a 1-lead patch recorder.
Eligibility criteria
Qualifiers
18 years or older
Ischemic stroke
Without known AF or those with previously diagnosed paroxysmal AF exhibiting sinus rhythm upon admission
Disqualifiers
AF at hosptial admission
Unable or unwilling to provide informed consent
A life expectancy of less than one year
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.